Aziz Mottiwala's Net Worth
$2.26 Million
Who is Aziz Mottiwala?
Aziz Mottiwala has an estimated net worth of $2.26 Million. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., and OPIANT PHARMACEUTICALS, INC..
SEC CIK
Aziz Mottiwala's CIK is 0001788542
Past Insider Trading and Trends
2022 was Aziz Mottiwala's most active year for acquiring shares with 4 total transactions. Aziz Mottiwala's most active month to acquire stocks was the month of February. 2023 was Aziz Mottiwala's most active year for disposing of shares, totalling 11 transactions. Aziz Mottiwala's most active month to dispose stocks was the month of February. 2022 saw Aziz Mottiwala paying a total of $48,879.24 for 89,660 shares, this is the most they've acquired in one year. In 2021 Aziz Mottiwala cashed out on 17,536 shares for a total of $323,310.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.80% | 8.17K |
$30.60 | -$145,839.60 | 54.08K |
Mar 15 - Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -4.98% | -2.40K |
$20.05 | -$48,120.00 | 45.81K |
Jul 19
| |||
Form 4
| -0.21% | -100.00 |
$20.00 | -$2,000.00 | 48.09K |
Jun 8
| |||
Form 4
| -8.79% | -4.64K |
$19.00 | -$88,231.23 | 48.19K |
Jun 6 - Jun 7
| |||
Form 4
| -2.00% | -1.08K |
$12.55 | -$13,530.89 | 52.83K |
Mar 21 - Mar 23
| |||
Form 4
| -1.28% | -697.00 |
$12.94 | -$9,016.30 | 53.91K |
Mar 17 - Mar 20
| |||
Form 4
| +8.88% | 4.45K |
$13.43 | -$4,512.48 | 54.6K |
Mar 15 - Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -12.12% | -6.86K |
$17.72 | -$121,506.04 | 49.73K |
Scheduled
|
Nov 15
| ||
Form 4
| +10.09% | 5.19K |
$9.42 | $48,879.24 | 56.59K |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| -3.63% | -1.89K |
$28.11 | -$53,099.79 | 50.2K |
Scheduled
|
Nov 8
| ||
Form 4
| -0.21% | -111.00 |
$28.04 | -$3,112.21 | 52.09K |
Scheduled
|
Nov 4 - Nov 5
| ||
Form 4
| -10.31% | -6.00K |
$26.78 | -$160,690.36 | 52.2K |
Scheduled
|
Nov 2
| ||
Form 4
| +8.08% | 4.35K |
$14.60 | -$8,461.60 | 58.2K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPIANT PHARMACEUTICALS, INC. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||